跳至主要内容
临床试验/NL-OMON56709
NL-OMON56709尚未招募不适用

Power2Walk: The Impact of Functional Power Training on Participation and Activity in Children with Cerebral Palsy - A Randomized Controlled Trial. - Power2Walk

Amsterdam UMC0 个研究点目标入组 66 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
66

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 至 15(—)

入选标准

  • - Children with cerebral palsy or a related non-progressive disorder between
  • the ages of 4 and 12.
  • - Gross Motor Function Classification System (GMFCS) level I - III.
  • - Parents and/or children have a treatment question related to either walking
  • ability and/or participation of their child.

排除标准

  • - Participants that suffer from a progressive neurological disorder.
  • - Treatment with botulinum toxin and/or serial casting in lower extremities
  • planned during the study.
  • - Treatment with botulinum toxin in the 12 weeks prior to the study.
  • - Treatment with serial casting in the 3 weeks prior to the study.
  • - Children that underwent a selective dorsal rhizotomy in the 12 months before
  • participation in the study.
  • - Children that underwent orthopedic surgery on their lower extremities in the
  • 12 months before participation in the study.
  • - Children that have already received MegaPower training in the last 4 months
  • before participation in the study
  • - Children for whom walking is not their preferred method of locomotion (yet).

研究者

发起方
Amsterdam UMC

相似试验